18.000
−4,76%
2026-10-19
Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +262.2% | +364.3% | 3 / 3 | -1.5% | +10.05 pp | +9.14 pp | +25.9% | 0.00 | 4.58 | 871 | −1,5% | 109 | +262,2% | 4.58 | -4.67 | — |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 18.000 (close price on 2026-10-19)EPS (TTM): 3.929
Financial charts
1.Revenue & growth
VND bn871Q2/26
1.Revenue & growth
VND bn871Q2/26
2.Profit & growth
VND bn109Q2/26
3.Profit mix (Penman)
VND bn362Q2/26
4.Margins & cost structure
%13.8%Q2/26
5.Returns & cash cycle
% · days32.8%Q2/26
6.Earnings quality & cash
VND bn157Q2/26
7.Asset structure
VND bn2.091Q2/26
8.Funding & debt health
VND bn · times2.091Q2/26
9.Revenue backlog
VND bn21,8Q2/26
10.Valuation
times · %4,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.249Q2/26
Adjusted EPS growth, latest quarter
262%
Average adjusted EPS growth, 3 quarters
479%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26